Feasibility of latent tuberculosis infection diagnosis by interferon-γ release assay remote from testing facilities
DOI:
https://doi.org/10.33321/cdi.2011.35.13Keywords:
tuberculin test, tuberculosis, interferon-gamma release assay, rural health servicesAbstract
Although the tuberculin skin test (TST) has been the mainstay of the diagnosis of latent tuberculosis infection (LTBI) for many decades, interferon-gamma release assays (IGRAs) are gaining acceptance and are more specific for this diagnosis. The characteristics of one such IGRA, the QuantiFERON®-TB Gold Whole Blood In-Tube, make it feasible for use in a remote setting. This study performed 62 IGRAs with this test on individuals testing positive by TST, in a clinical setting over 3,000 km from the testing laboratory. Of these, 42 patients (68%) recorded negative results, 19 (31%) were positive, with only 1 result (2%) indeterminate. Negative, and therefore discordant in this study, test results were more common in those known to have been previously vaccinated with bacille Calmette-Guérin. These results are consistent with other reports, indicating that this approach to testing is logistically feasible, and has the potential to complement LTBI screening to assist tuberculosis control programs in settings remote from the testing laboratory. Commun Dis Intell 2011;35(2):168–171.
Downloads
References
World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. 2009. Accessed July 2010. Available from: http://whqlibdoc.who.int/publications/2009/9789241598866_eng.pdf
Barry C, Konstantinos A. Tuberculosis notifications in Australia, 2007. Commun Dis Intell 2009;33(3):304–315.
Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17(6):968–975.
Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Int Med 2007;146(5):340–354.
Department of Immigration and Citizenship. Health Undertaking. 2009. Accessed August 2010. Available from: http://www.immi.gov.au/allforms/pdf/815.pdf
Department of Immigration and Citizenship. Supplement to form 1163i, complete country listing for the health assessment matrix. 2009. Accessed July 2010. Available from: http://www.immi.gov.au/allforms/health-requirements/1163i-supplement.pdf
Centre for Disease Control, Northern Territory. Guidelines for the Control of Tuberculosis in the Northern Territory. 2008. Accessed August 2010. Available from: http://www.health.nt.gov.au/library/scripts/objectifyMedia.aspx?file=pdf/25/05.pdf&siteID=1&str_title=Tuberculosis%20Control%20Guidelines.pdf
Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Micrbiol 2010;48(8):2672–2676.
Torres Costa J, Sá R, Cardoso MJ, Silva R, Ferreira J, Ribeiro C, et al. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Eur Respir J 2009;34(6):1423–1428.
Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286(14):1740–1747.
Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006;6:47.
Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005;172(5):631–635.
Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 2010;59(RR–5):1–26.
National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.
National Tuberculosis Advisory Committee. Position statement on interferon-γ release immunoassays in the detection of latent tuberculosis infection. 2009. Accessed August 2010. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Conte bacille Calmette-Guérin nt/cdna-ntac-interferon.htm
Cellestis Limited. QuantiFERON-TB Gold Assay Quick Reference Guide. 2009. Accessed August 2010. Available from: http://www.cellestis.com/IRM/ Company/ShowPage.aspx?CPID=1593&EID=61165518
Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002;359(9315):1393–1401.
Ravn P, Demissie A, Eguale T, Wondwosson H, Lein D, Amoudy HA, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999;179(3):637–645.
Winje BA, Oftung F, Korsvold GE, Mannsåker T, Ly IN, Harstad I, et al. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. BMC Infect Dis 2008;8:140.
Lucas M, Nicol P, McKinnon E, Whidborne R, Lucas A, Thambiran A, et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax 2010;65(5):442–448.
van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, et al. Within subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009;180(1):49–58.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2011 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
